Skip to content
Screener

Puma Biotechnology PBYI Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$44.8MBeat by $2.8M
EPS-$0.04Beat by $0.09
Revenue estimate$42.0M
EPS estimate-$0.13

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$57.5M
EPS estimate$0.11

FAQ

When did Puma Biotechnology report Q1 2026 earnings?
Puma Biotechnology (PBYI) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Puma Biotechnology's Q1 2026 revenue and EPS?
Puma Biotechnology reported revenue of $44.8M and eps of $-0.04 for Q1 2026.
Did Puma Biotechnology beat estimates in Q1 2026?
Revenue beat the consensus estimate of $42.0M by $2.8M. EPS beat the consensus estimate of $-0.13 by $0.09.
How did Puma Biotechnology's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.6% from $46.0M a year earlier.
Where can I find Puma Biotechnology's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-015621) and the 10-Q periodic report (0001437749-26-015633) directly on SEC EDGAR. The filing index links above go to sec.gov.